Literature DB >> 26462035

Inhibitor of apoptosis proteins as intracellular signaling intermediates.

Andrew J Kocab1,2, Colin S Duckett2,3.   

Abstract

Inhibitor of apoptosis (IAP) proteins have often been considered inhibitors of cell death due to early reports that described their ability to directly bind and inhibit caspases, the primary factors that implement apoptosis. However, a greater understanding is evolving regarding the vital roles played by IAPs as transduction intermediates in a diverse set of signaling cascades associated with functions ranging from the innate immune response to cell migration to cell-cycle regulation. In this review, we discuss the functions of IAPs in signaling, focusing primarily on the cellular IAP (c-IAP) proteins. The c-IAPs are important components in tumor necrosis factor receptor superfamily signaling cascades, which include activation of the NF-κB transcription factor family. As these receptors modulate cell proliferation and cell death, the involvement of the c-IAPs in these pathways provides an additional means of controlling cellular fate beyond simply inhibiting caspase activity. Additionally, IAP-binding proteins, such as Smac and caspases, which have been described as having cell death-independent roles, may affect c-IAP activity in intracellular signaling. Collectively, the multi-faceted functions and complex regulation of the c-IAPs illustrate their importance as intracellular signaling intermediates.
© 2015 FEBS.

Entities:  

Keywords:  NF-κB; Smac; Smac mimetic; apoptosis; caspases; cd30; cell signaling; inhibitor of apoptosis protein (IAP); tumor necrosis factor (TNF); ubiquitin-mediated signaling

Mesh:

Substances:

Year:  2015        PMID: 26462035      PMCID: PMC4767650          DOI: 10.1111/febs.13554

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  86 in total

1.  A novel role for XIAP in copper homeostasis through regulation of MURR1.

Authors:  Ezra Burstein; Lakshmanan Ganesh; Robert D Dick; Bart van De Sluis; John C Wilkinson; Leo W J Klomp; Cisca Wijmenga; George J Brewer; Gary J Nabel; Colin S Duckett
Journal:  EMBO J       Date:  2003-12-18       Impact factor: 11.598

2.  Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes.

Authors:  Olivier Micheau; Jürg Tschopp
Journal:  Cell       Date:  2003-07-25       Impact factor: 41.582

3.  The ubiquitin-associated domain of cellular inhibitor of apoptosis proteins facilitates ubiquitylation.

Authors:  Rhesa Budhidarmo; Catherine L Day
Journal:  J Biol Chem       Date:  2014-07-26       Impact factor: 5.157

4.  Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation.

Authors:  Gongxian Liao; Minying Zhang; Edward W Harhaj; Shao-Cong Sun
Journal:  J Biol Chem       Date:  2004-04-14       Impact factor: 5.157

5.  Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling.

Authors:  Sivakumar Vallabhapurapu; Atsushi Matsuzawa; Weizhou Zhang; Ping-Hui Tseng; Jonathan J Keats; Haopeng Wang; Dario A A Vignali; P Leif Bergsagel; Michael Karin
Journal:  Nat Immunol       Date:  2008-11-09       Impact factor: 25.606

6.  The yeast kinase Swe1 is required for proper entry into cell cycle after arrest due to ribosome biogenesis and protein synthesis defects.

Authors:  Francesca Saracino; Jochen Bassler; Diego Muzzini; Ed Hurt; Maria Luisa Agostoni Carbone
Journal:  Cell Cycle       Date:  2004-05-15       Impact factor: 4.534

7.  Degradation of DIAP1 by the N-end rule pathway is essential for regulating apoptosis.

Authors:  Mark Ditzel; Rebecca Wilson; Tencho Tenev; Anna Zachariou; Angela Paul; Emma Deas; Pascal Meier
Journal:  Nat Cell Biol       Date:  2003-05       Impact factor: 28.824

8.  IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis.

Authors:  Mads Gyrd-Hansen; Maurice Darding; Maria Miasari; Massimo M Santoro; Lars Zender; Wen Xue; Tencho Tenev; Paula C A da Fonseca; Marketa Zvelebil; Janusz M Bujnicki; Scott Lowe; John Silke; Pascal Meier
Journal:  Nat Cell Biol       Date:  2008-10-19       Impact factor: 28.824

9.  Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells.

Authors:  Qi-Heng Yang; Chunying Du
Journal:  J Biol Chem       Date:  2004-02-11       Impact factor: 5.157

10.  Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity.

Authors:  Aaron D Schimmer; Kate Welsh; Clemencia Pinilla; Zhiliang Wang; Maryla Krajewska; Marie-Josee Bonneau; Irene M Pedersen; Shinichi Kitada; Fiona L Scott; Beatrice Bailly-Maitre; Gennadi Glinsky; Dominick Scudiero; Edward Sausville; Guy Salvesen; Adel Nefzi; John M Ostresh; Richard A Houghten; John C Reed
Journal:  Cancer Cell       Date:  2004-01       Impact factor: 31.743

View more
  24 in total

1.  IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT Cells.

Authors:  Eleanor Clancy-Thompson; Lestat Ali; Patrick T Bruck; Mark A Exley; Richard S Blumberg; Glenn Dranoff; Michael Dougan; Stephanie K Dougan
Journal:  Cancer Immunol Res       Date:  2017-11-29       Impact factor: 11.151

2.  The Spatiotemporal Pattern and Intensity of p53 Activation Dictates Phenotypic Diversity in p53-Driven Developmental Syndromes.

Authors:  Margot E Bowen; Jacob McClendon; Hannah K Long; Aryo Sorayya; Jeanine L Van Nostrand; Joanna Wysocka; Laura D Attardi
Journal:  Dev Cell       Date:  2019-06-06       Impact factor: 12.270

Review 3.  Drosophila caspases as guardians of host-microbe interactions.

Authors:  Christa Kietz; Annika Meinander
Journal:  Cell Death Differ       Date:  2022-07-09       Impact factor: 15.828

4.  Cellular inhibitor of apoptosis 2 (cIAP2) restricts neuroinflammation during experimental autoimmune encephalomyelitis.

Authors:  Debolina D Biswas; Rebecca K Martin; LaShardai N Brown; Karli Mockenhaupt; Angela S Gupta; Michael J Surace; Anuj Tharakan; Jessie W Yester; Reetika Bhardwaj; Daniel H Conrad; Tomasz Kordula
Journal:  J Neuroinflammation       Date:  2022-06-19       Impact factor: 9.587

5.  Berbamine suppresses cell viability and induces apoptosis in colorectal cancer via activating p53-dependent apoptotic signaling pathway.

Authors:  Heng Zhang; Yunping Jiao; Chunyang Shi; Xiao Song; Ying Chang; Yong Ren; Xiaolin Shi
Journal:  Cytotechnology       Date:  2017-09-30       Impact factor: 2.058

6.  cIAP1/2 antagonism eliminates MHC class I-negative tumors through T cell-dependent reprogramming of mononuclear phagocytes.

Authors:  Kevin Roehle; Li Qiang; Katherine S Ventre; Daniel Heid; Lestat R Ali; Patrick Lenehan; Max Heckler; Stephanie J Crowley; Courtney T Stump; Gabrielle Ro; Anže Godicelj; Aladdin M Bhuiyan; Annan Yang; Maria Quiles Del Rey; Tamara Biary; Adrienne M Luoma; Patrick T Bruck; Jana F Tegethoff; Svenja L Nopper; Jinyang Li; Katelyn T Byrne; Marc Pelletier; Kai W Wucherpfennig; Ben Z Stanger; James J Akin; Joseph D Mancias; Judith Agudo; Michael Dougan; Stephanie K Dougan
Journal:  Sci Transl Med       Date:  2021-05-19       Impact factor: 19.319

7.  Necroptosis Execution Is Mediated by Plasma Membrane Nanopores Independent of Calcium.

Authors:  Uris Ros; Aida Peña-Blanco; Kay Hänggi; Ulrich Kunzendorf; Stefan Krautwald; W Wei-Lynn Wong; Ana J García-Sáez
Journal:  Cell Rep       Date:  2017-04-04       Impact factor: 9.423

8.  IAP antagonists sensitize murine osteosarcoma cells to killing by TNFα.

Authors:  Tanmay M Shekhar; Mark A Miles; Ankita Gupte; Scott Taylor; Brianna Tascone; Carl R Walkley; Christine J Hawkins
Journal:  Oncotarget       Date:  2016-06-07

9.  iTRAQ-Based Quantitative Proteomic Analysis of the Inhibitory Effects of Polysaccharides from Viscum coloratum (Kom.) Nakai on HepG2 Cells.

Authors:  Yangyang Chai; Min Zhao
Journal:  Sci Rep       Date:  2017-07-04       Impact factor: 4.379

10.  Preclinical assesement of survivin and XIAP as prognostic biomarkers and therapeutic targets in gastroenteropancreatic neuroendocrine neoplasia.

Authors:  Levent Dizdar; Kira A Oesterwind; Jasmin C Riemer; Thomas A Werner; Sabrina Mersch; Birte Möhlendick; Sina C Schütte; Pablo E Verde; Katharina Raba; Stefan A Topp; Nikolas H Stoecklein; Irene Esposito; Wolfram T Knoefel; Andreas Krieg
Journal:  Oncotarget       Date:  2017-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.